Overview

Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma

Status:
Completed
Trial end date:
2019-06-30
Target enrollment:
Participant gender:
Summary
This phase III trial is studying how well combination chemotherapy works when given before radiation therapy and/or additional chemotherapy in treating young patients with newly diagnosed Hodgkin's lymphoma. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill cancer cells. Giving more than one drug (combination chemotherapy) and giving them together with radiation therapy may kill more cancer cells.
Phase:
Phase 3
Details
Lead Sponsor:
Children's Oncology Group
Collaborator:
National Cancer Institute (NCI)
Treatments:
Cyclophosphamide
Cytarabine
Dexamethasone
Doxorubicin
Etoposide
Etoposide phosphate
Ifosfamide
Lenograstim
Liposomal doxorubicin
Prednisone
Vincristine
Vinorelbine